-
公开(公告)号:US20200308231A9
公开(公告)日:2020-10-01
申请号:US16206944
申请日:2018-11-30
发明人: Bradley L. Pentelute , Faycal Touti
摘要: The present invention provides novel peptides (e.g., peptides, macrocyclic peptides, mini-proteins) that modulate protein-protein interactions or salts thereof, and methods of making and using the inventive peptides. In some embodiments, the peptides are high affinity inhibitors (e.g., KD of at most 100 nM, at most 10 nM, at most 1 nM) of a protein-protein interaction. In certain embodiments, these peptides interfere with p53-MDM2 binding interactions (e.g., by binding to MDM2 (GenBank® Gene ID: 4193)). In some embodiments, the peptides interfere with the dimerization of the C-terminal domain of the human immunodeficiency virus (HIV) capsid protein (C-CA), comprising residues 146-231 of the HIV capsid protein (e.g., by binding to the C-terminal domain of the HIV capsid protein (C-CA), thereby inhibiting the dimeric interface of HIV capsid protein, thereby inhibiting viral assembly). These inventive peptides were rapidly generated and identified using novel methods described herein comprising combinatorial peptide synthesis and/or solution affinity selection.
-
公开(公告)号:US09868759B2
公开(公告)日:2018-01-16
申请号:US14853683
申请日:2015-09-14
发明人: Mark David Simon , Bradley L. Pentelute , Andrea Adamo , Patrick Louis Heider , Klavs F. Jensen
摘要: Systems and processes for performing solid phase peptide synthesis are generally described. Solid phase peptide synthesis is a known process in which amino acid residues are added to peptides that have been immobilized on a solid support. In certain embodiments, the inventive systems and methods can be used to perform solid phase peptide synthesis quickly while maintaining high yields. Certain embodiments relate to processes and systems that may be used to heat, transport, and/or mix reagents in ways that reduce the amount of time required to perform solid phase peptide synthesis.
-
公开(公告)号:US20150152134A1
公开(公告)日:2015-06-04
申请号:US14402915
申请日:2013-05-21
CPC分类号: A61K47/6811 , A61K31/7056 , A61K39/395 , A61K47/64 , A61K47/641 , A61K47/6415 , C07K1/047 , C07K1/107 , C07K2/00 , C12P21/06
摘要: Proteins containing a C-terminal thioester are important intermediates in semi-synthesis. Currently there is one main method for the synthesis of protein thioesters that relies upon the use of engineered inteins. The invention involves, in some aspects a method, utilizing Sortase A, for preparation of recombinant proteins containing a C-terminal αthioester. This new method for double ligatation is useful for synthesizing new or naturally occurring molecules such as a protein thioester.
摘要翻译: 含有C-末端硫酯的蛋白质是半合成中的重要中间体。 目前,有一种主要依靠工程化内含肽的蛋白质硫酯的合成方法。 本发明在一些方面涉及利用分选酶A制备含有C端α硫酯的重组蛋白的方法。 这种双重连接的新方法可用于合成新的或天然存在的分子,如蛋白质硫酯。
-
公开(公告)号:US20220289750A1
公开(公告)日:2022-09-15
申请号:US17561680
申请日:2021-12-23
IPC分类号: C07D487/04 , C07D487/14 , C07D519/00 , C07D209/86 , C07D498/22 , C07D487/22
摘要: The present disclosure provides compounds of Formula I, methods of preparing the compounds, compositions, kits, and methods of using the compounds for treating or preventing microbial infections.
-
公开(公告)号:US20220033795A1
公开(公告)日:2022-02-03
申请号:US17402323
申请日:2021-08-13
摘要: Embodied herein are engineered fusion proteins that bind and target nociceptor neurons, compositions comprising these engineered fusion proteins, and methods for treatment of pain using these engineered fusion proteins or compositions containing the engineered fusion proteins. The engineered fusion proteins contain domains derived from protein toxins such as the anthrax toxin, clostridial botulinum family of toxins, disulphide-containing toxins, and AB component type toxins.
-
公开(公告)号:US20210047365A1
公开(公告)日:2021-02-18
申请号:US16874824
申请日:2020-05-15
发明人: Dale Arlington Thomas , Alexander James Mijalis , Bradley L. Pentelute , Mark David Simon , Surin Mong
IPC分类号: C07K1/04 , C07K14/60 , C07K7/06 , C07K14/47 , C07K14/61 , C07K14/62 , G01N21/33 , G01N33/487
摘要: Methods and systems for control of solid phase peptide synthesis are generally described. Control of solid phase peptide synthesis involves the use of feedback from one or more reactions and/or processes (e.g., reagent removal) taking place in the solid phase peptide synthesis system. In some embodiments, a detector may detect one or more fluids flowing across a detection zone of a solid phase peptide synthesis system and one or more signals may be generated corresponding to the fluid(s). For instance, an electromagnetic radiation detector positioned downstream of a reactor may detect a fluid exiting the reactor after a deprotection reactor and produce a signal(s). In some embodiments, based at least in part on information derived from the signal(s), a parameter of the system may be modulated prior to and/or during one or more subsequent reactions and/or processes taking place in the solid phase peptide synthesis system. In some embodiments, the methods and systems, described herein, can be used to conduct quality control to determine and correct problems (e.g., aggregation, truncation, deletion) in reactions (e.g., coupling reactions) taking place in the solid phase peptide synthesis system.
-
公开(公告)号:US10704035B2
公开(公告)日:2020-07-07
申请号:US15755543
申请日:2016-08-26
摘要: Embodied herein are engineered fusion proteins that bind and target nociceptor neurons, compositions comprising these engineered fusion proteins, and methods for treatment of pain using these engineered fusion proteins or compositions containing the engineered fusion proteins. The engineered fusion proteins contain domains derived from protein toxins such as the anthrax toxin, clostridial botulinum family of toxins, disulphide-containing toxins, and AB component type toxins.
-
公开(公告)号:US20200061201A1
公开(公告)日:2020-02-27
申请号:US16550036
申请日:2019-08-23
发明人: Zeyu Lu , Bradley L. Pentelute
摘要: The present invention relates to compositions and methods associated with antibody-bacterial effector translocase protein conjugates. Some aspects of the present invention relate to preventing or treating diseases using the antibody-protective antigen conjugates. Further aspects of the present invention relate to methods of chemically conjugating and synthesizing the antibody-bacterial effector translocase protein conjugates.
-
公开(公告)号:US20170081359A1
公开(公告)日:2017-03-23
申请号:US15267995
申请日:2016-09-16
发明人: Dale Arlington Thomas, III , Alexander James Mijalis , Bradley L. Pentelute , Mark David Simon , Andrea Adamo , Patrick Louis Heider , Klavs F. Jensen
CPC分类号: C07K1/084 , B01J19/24 , B01J2219/24 , C07K1/045 , C07K7/06 , C07K14/47 , C07K14/60 , C07K14/61 , C07K14/62
摘要: Methods and system for solid phase peptide synthesis are provided. Solid phase peptide synthesis is a known process in which amino acid residues are added to peptides that have been immobilized on a solid support. New amino acid residues are added via a coupling reaction between an activated amino acid and an amino acid residue of the immobilized peptide. Amino acids may be activated using, e.g., a base and an activating agent. Certain inventive concepts, described herein, relate to methods and systems for the activation of amino acids. These systems and methods may allow for fewer side reactions and a higher yield compared to conventional activation techniques as well as the customization of the coupling reaction on a residue-by-residue basis without the need for costly and/or complex processes.
-
公开(公告)号:US20170081358A1
公开(公告)日:2017-03-23
申请号:US15268032
申请日:2016-09-16
发明人: Dale Arlington Thomas, III , Alexander James Mijalis , Bradley L. Pentelute , Mark David Simon , Surin Mong
IPC分类号: C07K1/04 , C07K14/47 , C07K14/61 , G01N21/33 , G01N33/487 , G01N21/27 , G01N21/3577 , C07K7/06 , C07K14/62
CPC分类号: C07K1/045 , C07K7/06 , C07K14/47 , C07K14/60 , C07K14/61 , C07K14/62 , G01N21/272 , G01N21/33 , G01N21/3577 , G01N33/48707 , G01N2021/8416
摘要: Methods and systems for control of solid phase peptide synthesis are generally described. Control of solid phase peptide synthesis involves the use of feedback from one or more reactions and/or processes (e.g., reagent removal) taking place in the solid phase peptide synthesis system. In some embodiments, a detector may detect one or more fluids flowing across a detection zone of a solid phase peptide synthesis system and one or more signals may be generated corresponding to the fluid(s). For instance, an electromagnetic radiation detector positioned downstream of a reactor may detect a fluid exiting the reactor after a deprotection reactor and produce a signal(s). In some embodiments, based at least in part on information derived from the signal(s), a parameter of the system may be modulated prior to and/or during one or more subsequent reactions and/or processes taking place in the solid phase peptide synthesis system. In some embodiments, the methods and systems, described herein, can be used to conduct quality control to determine and correct problems (e.g., aggregation, truncation, deletion) in reactions (e.g., coupling reactions) taking place in the solid phase peptide synthesis system.
-
-
-
-
-
-
-
-
-